MetaADEDB 2.0 @ LMMD
hydrochlorothiazide, lisinopril drug combination
(BFNXYSZBURSNHS-UVJOBNTFSA-N)
Structure
SMILES
Clc1cc2NCNS(=O)(=O)c2cc1S(=O)(=O)N.NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N[C@H](C(=O)O)CCc1ccccc1
Molecular Formula:
C28H39ClN6O9S2
Molecular Weight:
703.227
Log P:
5.2417
Hydrogen Bond Acceptor:
15
Hydrogen Bond Donor:
7
TPSA:
268.08
CAS Number(s):
151063-30-8
Synonym(s)
1.
hydrochlorothiazide, lisinopril drug combination
2.
Zestoretic
3.
hydrochlorothiazide - lisinopril
External Link(s)
MeSHC091365
PubChem Compound44147212
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AngioedemaFAERS: 1917860891CTD
US FAERS
2DizzinessFAERS: 52US FAERS
3Drug ineffectiveFAERS: 37
Canada Vigilance: 6
Canada Vigilance
US FAERS
4NauseaFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
5HeadacheFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
6FatigueFAERS: 25US FAERS
7Product substitution issueFAERS: 23
Canada Vigilance: 5
Canada Vigilance
US FAERS
8Lip swellingFAERS: 22US FAERS
9Feeling abnormalFAERS: 20US FAERS
10Pharmaceutical product complaintFAERS: 18US FAERS
11PalpitationsFAERS: 16US FAERS
12AstheniaFAERS: 15US FAERS
13PruritusFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
14Chest PainFAERS: 14US FAERS
15Product quality issueFAERS: 14US FAERS
16HypersensitivityFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
17VomitingFAERS: 13US FAERS
18SyncopeFAERS: 12US FAERS
19Burning sensationFAERS: 11US FAERS
20MalaiseFAERS: 11US FAERS
21UrticariaFAERS: 11US FAERS
22WheezingFAERS: 11US FAERS
23Blood pressure inadequately controlledFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
24HypotensionFAERS: 10US FAERS
25Abdominal PainFAERS: 9US FAERS
26Back PainFAERS: 9US FAERS
27Musculoskeletal PainFAERS: 9US FAERS
28DysphoniaFAERS: 8US FAERS
29Oropharyngeal painFAERS: 8US FAERS
30PainFAERS: 8US FAERS
31SwellingFAERS: 8US FAERS
32Abdominal discomfortFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
33DehydrationFAERS: 7US FAERS
34AmnesiaFAERS: 6US FAERS
35ArthralgiaFAERS: 6US FAERS
36Blood creatinine increasedFAERS: 6US FAERS
37Therapeutic response unexpected with drug substitutionFAERS: 6US FAERS
38Throat irritationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
39Blood urea increasedFAERS: 5US FAERS
40BronchitisFAERS: 5US FAERS
41Chest discomfortFAERS: 5US FAERS
42Drug dispensing errorFAERS: 5US FAERS
43Drug dose omissionFAERS: 5US FAERS
44LethargyFAERS: 5US FAERS
45RetchingFAERS: 5US FAERS
46Urinary tract infectionFAERS: 5US FAERS
47AlopeciaFAERS: 4US FAERS
48AsthmaFAERS: 4US FAERS
49Ear discomfortFAERS: 4US FAERS
50Hypoaesthesia facialFAERS: 4US FAERS
51Incorrect dose administeredFAERS: 4US FAERS
52Joint swellingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
53MyalgiaFAERS: 4US FAERS
54No adverse eventFAERS: 4US FAERS
55PancreatitisFAERS: 4US FAERS
56Respiratory distressFAERS: 4US FAERS
57TremorFAERS: 4US FAERS
58Weight decreasedFAERS: 4US FAERS
59AbasiaFAERS: 3US FAERS
60Adverse eventFAERS: 3US FAERS
61AgitationFAERS: 3US FAERS
62AphasiaFAERS: 3US FAERS
63Blood glucose increasedFAERS: 3US FAERS
64Cardiac ArrestFAERS: 3US FAERS
65ChokingFAERS: 3US FAERS
66Diabetes MellitusFAERS: 3US FAERS
67DisorientationFAERS: 3US FAERS
68ErythemaFAERS: 3US FAERS
69Impaired work abilityFAERS: 3US FAERS
70Medication ErrorFAERS: 3US FAERS
71Multiple allergiesFAERS: 3US FAERS
72Musculoskeletal stiffnessFAERS: 3US FAERS
73Peripheral swellingFAERS: 3US FAERS
74Product physical issueFAERS: 3US FAERS
75Renal painFAERS: 3US FAERS
76RestlessnessFAERS: 3US FAERS
77ThirstFAERS: 3US FAERS
78TinnitusFAERS: 3US FAERS
79Urinary RetentionFAERS: 3US FAERS
80Acute prerenal failureFAERS: 2US FAERS
81Acute respiratory failureFAERS: 2US FAERS
82AphoniaFAERS: 2US FAERS
83ArthropathyFAERS: 2US FAERS
84Blood pressure fluctuationFAERS: 2US FAERS
85Blood sodium decreasedFAERS: 2US FAERS
86ChillsFAERS: 2US FAERS
87Completed SuicideFAERS: 2US FAERS
88Drug level above therapeuticFAERS: 2US FAERS
89DysarthriaFAERS: 2US FAERS
90DysgeusiaFAERS: 2US FAERS
91DyspepsiaFAERS: 2US FAERS
92EczemaFAERS: 2US FAERS
93Eye painFAERS: 2US FAERS
94FlushingFAERS: 2US FAERS
95Gluten sensitivityFAERS: 2US FAERS
96GoutFAERS: 2US FAERS
97HyperkeratosisFAERS: 2US FAERS
98HypoxiaFAERS: 2US FAERS
99Impaired driving abilityFAERS: 2US FAERS
100IncontinenceFAERS: 2US FAERS
101Increased upper airway secretionFAERS: 2US FAERS
102Intentional drug misuseFAERS: 2US FAERS
103LymphadenopathyFAERS: 2US FAERS
104Middle insomniaFAERS: 2US FAERS
105NasopharyngitisFAERS: 2US FAERS
106Neck PainFAERS: 2US FAERS
107NervousnessFAERS: 2US FAERS
108PneumoniaFAERS: 2US FAERS
109Poor quality drug administeredFAERS: 2US FAERS
110Productive CoughFAERS: 2US FAERS
111PseudolymphomaFAERS: 2US FAERS
112PurpuraFAERS: 2US FAERS
113Respiratory arrestFAERS: 2US FAERS
114Sleep disorder due to general medical condition, insomnia typeFAERS: 2US FAERS
115SomnolenceFAERS: 2US FAERS
116TachycardiaFAERS: 2US FAERS
117Unevaluable eventFAERS: 2US FAERS
118Unresponsive to stimuliFAERS: 2US FAERS
119Urinary IncontinenceFAERS: 2US FAERS
120Visual ImpairmentFAERS: 2US FAERS
121Wrong technique in product usage processFAERS: 2US FAERS
122Alcohol withdrawal syndromeFAERS: 1US FAERS
123Allergy to arthropod stingFAERS: 1US FAERS
124Anaphylactic shockFAERS: 1US FAERS
125Anaphylactoid ReactionFAERS: 1US FAERS
126Ankle FractureFAERS: 1US FAERS
127AnorgasmiaFAERS: 1US FAERS
128AnosmiaFAERS: 1US FAERS
129AnuriaFAERS: 1US FAERS
130AnxietyFAERS: 1US FAERS
131ArthritisFAERS: 1US FAERS
132Arthropod biteFAERS: 1US FAERS
133Bladder painFAERS: 1US FAERS
134Blood cholesterolFAERS: 1US FAERS
135Blood creatine increasedFAERS: 1US FAERS
136Blood glucose fluctuationFAERS: 1US FAERS
137Blood potassium decreasedFAERS: 1US FAERS
138Blood potassium increasedFAERS: 1US FAERS
139Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
140BradycardiaFAERS: 1US FAERS
141BronchospasmFAERS: 1US FAERS
142BruxismFAERS: 1US FAERS
143Cardiac FlutterFAERS: 1US FAERS
144Carpal Tunnel SyndromeFAERS: 1US FAERS
145CellulitisFAERS: 1US FAERS
146Cerebrovascular accidentFAERS: 1US FAERS
147ChromaturiaFAERS: 1US FAERS
148Chronic Fatigue SyndromeFAERS: 1US FAERS
149Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
150ConstipationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
151Coronary Artery DiseaseFAERS: 1US FAERS
152CryingFAERS: 1US FAERS
153Diabetes mellitus inadequate controlFAERS: 1US FAERS
154Diastolic dysfunctionFAERS: 1US FAERS
155DisabilityFAERS: 1US FAERS
156DiscomfortFAERS: 1US FAERS
157Documented hypersensitivity to administered drugFAERS: 1US FAERS
158DroolingFAERS: 1US FAERS
159Drug abuseFAERS: 1US FAERS
160Drug administered to patient of inappropriate ageFAERS: 1US FAERS
161Drug dispensed to wrong patientFAERS: 1US FAERS
162Drug prescribing errorFAERS: 1US FAERS
163Dry skinFAERS: 1US FAERS
164DysuriaFAERS: 1US FAERS
165Electrocardiogram changeFAERS: 1US FAERS
166Emotional disorderFAERS: 1US FAERS
167Erectile dysfunctionFAERS: 1US FAERS
168Erythema MultiformeFAERS: 1US FAERS
169Facial PainFAERS: 1US FAERS
170Feelings of worthlessnessFAERS: 1US FAERS
171FibromyalgiaFAERS: 1US FAERS
172FlatulenceFAERS: 1US FAERS
173FrustrationFAERS: 1US FAERS
174Gastrointestinal PainFAERS: 1US FAERS
175Gingival HyperplasiaFAERS: 1US FAERS
176Gingival erythemaFAERS: 1US FAERS
177HemiparesisFAERS: 1US FAERS
178HypersomniaFAERS: 1US FAERS
179Hypertensive crisisFAERS: 1US FAERS
180HypoparathyroidismFAERS: 1US FAERS
181IleitisFAERS: 1US FAERS
182InfluenzaFAERS: 1US FAERS
183Joint InstabilityFAERS: 1US FAERS
184Joint stiffnessFAERS: 1US FAERS
185LacerationFAERS: 1US FAERS
186LaryngitisFAERS: 1US FAERS
187Lipase increasedFAERS: 1US FAERS
188Memory impairmentFAERS: 1US FAERS
189Mental status changesFAERS: 1US FAERS
190Mouth swellingFAERS: 1US FAERS
191Multiple SclerosisFAERS: 1US FAERS
192Musculoskeletal chest painFAERS: 1US FAERS
193NephrolithiasisFAERS: 1US FAERS
194Oral painFAERS: 1US FAERS
195Oropharyngeal blisteringFAERS: 1US FAERS
196Pain of skinFAERS: 1US FAERS
197PallorFAERS: 1US FAERS
198ParanoiaFAERS: 1US FAERS
199Periodontal destructionFAERS: 1US FAERS
200Personality ChangeFAERS: 1US FAERS
201PharyngitisFAERS: 1US FAERS
202Pityriasis Rubra PilarisFAERS: 1US FAERS
203PolyuriaFAERS: 1US FAERS
204PregnancyFAERS: 1US FAERS
205PresyncopeFAERS: 1US FAERS
206Product blister packaging issueFAERS: 1US FAERS
207Product dispensing errorFAERS: 1US FAERS
208Product expiration date issueFAERS: 1US FAERS
209Product formulation issueFAERS: 1US FAERS
210Product label on wrong productFAERS: 1US FAERS
211Product lot number issueFAERS: 1US FAERS
212Pulmonary EmbolismFAERS: 1US FAERS
213Quality of life decreasedFAERS: 1US FAERS
214Rash erythematousFAERS: 1US FAERS
215Reaction to azo-dyesFAERS: 1US FAERS
216Reaction to drug excipientsFAERS: 1US FAERS
217Respiratory DepressionFAERS: 1US FAERS
218Respiratory FailureFAERS: 1US FAERS
219Retinal phototoxicityFAERS: 1US FAERS
220Salivary gland painFAERS: 1US FAERS
221SarcoidosisFAERS: 1US FAERS
222Secretion dischargeFAERS: 1US FAERS
223Sinus TachycardiaFAERS: 1US FAERS
224Sinus bradycardiaFAERS: 1US FAERS
225Skin UlcerFAERS: 1US FAERS
226Skin irritationFAERS: 1US FAERS
227SluggishnessFAERS: 1US FAERS
228StaringFAERS: 1US FAERS
229Tablet physical issueFAERS: 1US FAERS
230Temperature intoleranceFAERS: 1US FAERS
231Tension HeadacheFAERS: 1US FAERS
232Therapeutic response unexpectedFAERS: 1US FAERS
233Toxicity to various agentsFAERS: 1US FAERS
234Urethritis noninfectiveFAERS: 1US FAERS
235VasculitisFAERS: 1US FAERS
236Ventricular hypertrophyFAERS: 1US FAERS
237White blood cell count abnormalFAERS: 1US FAERS
238Wrong drug administeredFAERS: 1US FAERS
239nervous system disorderFAERS: 1US FAERS
240GlossitisCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.